
Platikem 10mg Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Cisplatin (10mg)
Overview Platikem 10mg Injection
Ovacure 10mg Injection, a prescription medication, treats ovarian, cervical, and testicular cancers. Its mechanism involves inhibiting or reducing cancerous cell proliferation. Administered intravenously by a healthcare professional, dosage and frequency are determined by your physician based on your condition and may adjust over time. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits might not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include injection site inflammation (pain, swelling, redness), nausea, and vomiting. Serious side effects include hearing impairment, necessitating pre- and ongoing hearing assessments. The medication can lower blood cell counts (red and white), increasing infection risk, mandating regular blood tests monitoring blood cell levels, as well as heart, liver, and kidney function. Inform your physician of any existing or prior kidney conditions, as the medicine impacts kidney function. Interactions with other medications are possible; disclose all medications to your healthcare provider. This injection is contraindicated during pregnancy and breastfeeding. Male infertility is a potential consequence; sperm banking should be considered prior to treatment.
Uses of Platikem 10mg Injection
Cancers of the ovaries, cervix, and testes
Major Benefits of Platikem 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Platikem 10mg Injection:
- Injection site reactions (pain, swelling, redness)
- Increased risk of infection
- Ear disorder
- Vomiting
- Nausea
- Decreased blood cells (red cells, white cells, and platelets)
- Renal impairment
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Kidney damage
- Hearing loss
- Ringing in ear
How to use Platikem 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Platikem 10mg Injection works:
Oncokem 10mg Injection is a chemotherapeutic agent that inhibits cancer cell proliferation by targeting and disrupting the cellular DNA and RNA, thereby halting their growth and replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Platikem 10mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Platikem 10mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Platikem 10mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Platikem 10mg Injection can induce adverse reactions, including drowsiness and nausea, potentially impairing driving ability.
KidneyCAUTION
For individuals with kidney impairment, Platikem 10mg Injection requires careful administration; dosage modification may be necessary. Physician consultation is advised. Platikem 10mg Injection is contraindicated in patients exhibiting severe kidney dysfunction.
LiverSAFE IF PRESCRIBED
Platikem 10mg Injection appears to pose minimal risk for individuals with hepatic impairment. Preliminary evidence indicates dose modification may be unnecessary in this population. However, physician consultation is recommended.
What if you forget to take Platikem 10mg Injection :
Omit a dose of Platikem 10mg Injection? Seek medical advice immediately.
Facts to Know About Platikem 10mg Injection
| Label | Value |
|---|---|
| Type of Compound | Platinum-based compounds |
| Potential for Dependence | None. |
| Medication Classification | Cancer-fighting drugs |
| Mechanism of Action | Platinum-based antitumor agents |
